subscribeSubscribe
Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%

Merz wins $185m bid for bankrupt Acorda assets and increases US workforce by 50%
PHARMACEUTICAL-TECHNOLOGY
11 Jul 2024
Share Share
Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics

Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
BUSINESSWIRE
10 Jul 2024
Share Share
US FDA rejects AbbVie`s Parkinson`s disease therapy for the second time

US FDA rejects AbbVie`s Parkinson`s disease therapy for the second time
Fraiser Kansteiner FIERCE PHARMA
26 Jun 2024
Share Share
Rubicon`s Generic Carbidopa; Levodopa Receives Approval in US

Rubicon`s Generic Carbidopa; Levodopa Receives Approval in US
FDA
04 Jun 2024
Share Share
Mitsubishi Tanabe Pharma America Presents Positive Results from Pivotal Phase 3

Mitsubishi Tanabe Pharma America Presents Positive Results from Pivotal Phase 3
PR NEWSWIRE
29 Aug 2023
Share Share
JAMA Publishes Phase 3 Study Results Comparing IPX203 to Carbidopa/Levodopa

JAMA Publishes Phase 3 Study Results Comparing IPX203 to Carbidopa/Levodopa
BUSINESSWIRE
24 Aug 2023
Share Share
Vistagen Receives Notice of Allowance for AV-101 Canadian Patent

Vistagen Receives Notice of Allowance for AV-101 Canadian Patent
BUSINESSWIRE
13 Jul 2023
Share Share
US FDA declines to approve AbbVie`s Parkinson`s disease therapy

US FDA declines to approve AbbVie`s Parkinson`s disease therapy
HEALTH ET
23 Mar 2023
Share Share
Enforcement Report - Week of March 8, 2023

Enforcement Report - Week of March 8, 2023
FDA
08 Mar 2023
Share Share
Acorda Announces Agreement with Catalent for Long-Term Global Supply of INBRIJA®

Acorda Announces Agreement with Catalent for Long-Term Global Supply of INBRIJA®
BUSINESSWIRE
05 Jan 2023
Share Share